BioSpace News Archive

Pandemic underscores important role of endodontists and the need to protect them

Arena Pharmaceuticals, Inc. provided a corporate update and reported financial results for the first quarter ended March 31, 2020.

Accelerate Diagnostics, Inc., announced financial results for the quarter ending March 31, 2020 and provided a business update regarding the impact of the ongoing COVID-19 pandemic on the Company’s operations.

Kindred Biosciences, Inc., a biopharmaceutical company focused on saving and improving the lives of pets, announced financial results for the first quarter ended March 31, 2020 and provided updates on its programs.

Eiger BioPharmaceuticals, Inc., focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, reported financial results for first quarter 2020 and provided a business update.

Plus Therapeutics, Inc. announced that it will report its First Quarter Fiscal Year 2020 financial results after the close of market on May 14, 2020.

Dicerna Pharmaceuticals, Inc., a leading developer of investigational ribonucleic acid interference therapeutics, reported its financial results for the first quarter ended March 31, 2020.

Catasys, Inc., an AI and telehealth enabled, virtualized outpatient healthcare treatment company, reported its financial results for the first quarter ended March 31, 2020.

Axonics Modulation Technologies, Inc., a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation devices for the treatment of bladder and bowel dysfunction, announced that it has commenced a proposed public offering of $100,000,000 in shares of its common stock.

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced financial results for the first quarter ended March 31, 2020.